FI942938A0 - Soy protein or hydrolysates in pharmaceutical compositions for protection of bioactive peptides against enzymatic inactivation - Google Patents

Soy protein or hydrolysates in pharmaceutical compositions for protection of bioactive peptides against enzymatic inactivation

Info

Publication number
FI942938A0
FI942938A0 FI942938A FI942938A FI942938A0 FI 942938 A0 FI942938 A0 FI 942938A0 FI 942938 A FI942938 A FI 942938A FI 942938 A FI942938 A FI 942938A FI 942938 A0 FI942938 A0 FI 942938A0
Authority
FI
Finland
Prior art keywords
hydrolysates
protection
pharmaceutical compositions
soy protein
bioactive peptides
Prior art date
Application number
FI942938A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI942938A (en
Inventor
Gordon L Amidon
Glen D Leesman
Patrick J Sinko
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI942938A publication Critical patent/FI942938A/en
Publication of FI942938A0 publication Critical patent/FI942938A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2207—Gastrins; Cholecystokinins [CCK]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Botany (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI942938A 1991-12-18 1994-06-17 Soy protein or hydrolysates in pharmaceutical compositions for protection of bioactive peptides against enzymatic inactivation FI942938A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81059391A 1991-12-18 1991-12-18
PCT/US1992/009336 WO1993011799A1 (en) 1991-12-18 1992-11-09 Soybean protein or hydrolyzates in pharmaceutical compositions to protect bioactive peptides from enzymatic inactivation

Publications (2)

Publication Number Publication Date
FI942938A FI942938A (en) 1994-06-17
FI942938A0 true FI942938A0 (en) 1994-06-17

Family

ID=25204183

Family Applications (1)

Application Number Title Priority Date Filing Date
FI942938A FI942938A0 (en) 1991-12-18 1994-06-17 Soy protein or hydrolysates in pharmaceutical compositions for protection of bioactive peptides against enzymatic inactivation

Country Status (12)

Country Link
EP (1) EP0617626A1 (en)
JP (1) JPH06510796A (en)
AU (1) AU3058392A (en)
CA (1) CA2125400A1 (en)
FI (1) FI942938A0 (en)
HU (1) HUT69785A (en)
IL (1) IL104048A0 (en)
MX (1) MX9207407A (en)
NO (1) NO942323L (en)
PT (1) PT101135A (en)
WO (1) WO1993011799A1 (en)
ZA (1) ZA929761B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994007472A1 (en) * 1992-10-02 1994-04-14 Pfizer Inc. Pharmaceutical compositions containing nonionic surfactants
AU7273494A (en) * 1993-09-01 1995-03-22 Pfizer Inc. Pharmaceutical compositions containing anionic surfactants
US6852690B1 (en) 1995-08-22 2005-02-08 Amylin Pharmaceuticals, Inc. Method and composition for enhanced parenteral nutrition
DE19530865A1 (en) * 1995-08-22 1997-02-27 Michael Dr Med Nauck Active ingredient and agent for parenteral nutrition
IL150818A0 (en) * 2000-01-27 2003-02-12 Aqua Solution Inc Composition for intestinal delivery
GB0015921D0 (en) * 2000-06-30 2000-08-23 Nat Biolog Standards Board Improvements in or relating to stabilisation of substances
CL2008001640A1 (en) * 2007-06-08 2008-11-07 Bergen Teknologioverforing As Use of hydroxyproline to prepare an alloy composition intended to promote the growth of an animal, such as fish, birds and mammals.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4537769A (en) * 1982-04-06 1985-08-27 American Cyanamid Company Stabilization of influenza virus vaccine
IL68769A (en) * 1983-05-23 1986-02-28 Hadassah Med Org Pharmaceutical compositions containing insulin for oral administration
US4774089A (en) * 1985-06-14 1988-09-27 Albion International, Inc. Stimulation of gonadotropic hormones with mineral mixtures containing amino acid chelates
MY103189A (en) * 1986-10-31 1993-05-29 Pfizer Nor-statine and nor-cyclostatine polypeptides
ES2061688T3 (en) * 1987-11-13 1994-12-16 Smithkline Beecham Farma PHARMACEUTICAL COMPOSITIONS THAT INCLUDE A CALCITONINE AND A GLICIRRICINATE AS IMPROVER OF ABSORPTION.
IL90244A (en) * 1988-05-11 1993-05-13 Du Pont Merck Pharma Peptide-drug compositions, for buccal and nasal administration, containing :-aminoboronic acid derivatives
DD273980B5 (en) * 1988-07-12 1994-04-14 Berlin Chemie Ag Process for the preparation of insulin preparations for rectal use
GB8822857D0 (en) * 1988-09-29 1988-11-02 Patralan Ltd Pharmaceutical formulations
DK546289D0 (en) * 1989-11-02 1989-11-02 Danochemo As carotenoid

Also Published As

Publication number Publication date
WO1993011799A1 (en) 1993-06-24
AU3058392A (en) 1993-07-19
NO942323D0 (en) 1994-06-17
HU9401824D0 (en) 1994-09-28
PT101135A (en) 1994-03-31
MX9207407A (en) 1993-06-01
CA2125400A1 (en) 1993-06-24
IL104048A0 (en) 1993-05-13
JPH06510796A (en) 1994-12-01
HUT69785A (en) 1995-09-28
NO942323L (en) 1994-06-17
EP0617626A1 (en) 1994-10-05
FI942938A (en) 1994-06-17
ZA929761B (en) 1994-06-17

Similar Documents

Publication Publication Date Title
ATE136221T1 (en) OSTEO-INDUCTIVE PHARMACEUTICAL FORMULATIONS
HUP0002942A3 (en) Peptides having serine protease inhibiting effect pharmaceutical compositions comprising thereof and their use
ZA989740B (en) Cyclic amino acids and derivatives thereof useful as pharmaceutical agents
HUP0100669A3 (en) Peptide derivatives as serine protease inhibitors, their use and pharmaceutical compositions comprising thereof
DE69900746D1 (en) CONTROLLED ADMINISTRATION OF PEPTIDES OR PROTEINS
TR199501669A1 (en) Aerosol formulations of peptide and proteins.
DE69532996D1 (en) PEPTIDE ANALOGS OF THE HUMAN BASIC MYELINE PROTEIN
BR9607317A (en) Peptides and pharmaceutical composition
BR9607318A (en) Peptides and pharmaceutical composition
IL109867A0 (en) alpha-heteroaryloxymethyl ketones as interleukin -1beta protease inhibitors and pharmaceutical compositions containing them
HUP0100100A3 (en) Hepatitis c inhibitor peptide analogues, pharmaceutical compositions comprising thereof and their use
HUP0100149A3 (en) Antipicornaviral peptide derivatives pharmaceutical compositions comprising thereof and their use
SE0002202D0 (en) New peptides
MX9708727A (en) Novel variants of apolipoprotein a-i.
ATE230926T1 (en) SYNERGISTIC MIXTURES OF SELECTED AMINO ACIDS
DE69512929D1 (en) SALTS OF AMINO ALCOHOLS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
DE69520475D1 (en) Pharmaceutical composition of biologically active peptides or proteins
FI942938A (en) Soy protein or hydrolysates in pharmaceutical compositions for protection of bioactive peptides against enzymatic inactivation
IL133176A0 (en) Pharmaceutical compositions of peptides having low solubility in physiological medium
IT1277338B1 (en) PHARMACEUTICAL COMPOSITIONS OF CYCLOSPORINE OR OTHER PEPTIDE SUBSTANCES
CA2247998A1 (en) Fragments of cr1 and their use
BR9507063A (en) Peptide derived from peptide substitution and pharmaceutical composition
ATA114093A (en) MARKED ALPHA AMINO ACIDS
ITMI930311A0 (en) PHARMACEUTICAL COMPOSITIONS OF AMINO ACID DERIVATIVES
IL156956A0 (en) Cyclic amino acids and derivatives therefor useful as pharmaceutical agents

Legal Events

Date Code Title Description
FD Application lapsed